• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Pituitary Tumor Global Clinical Trials Review, H1, 2012 - Product Image

Pituitary Tumor Global Clinical Trials Review, H1, 2012

  • Published: February 2012
  • Region: Global
  • 75 pages
  • GlobalData

Pituitary Tumor Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Pituitary Tumor Global Clinical Trials Review, H1, 2012" provides data on the Pituitary Tumor clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pituitary Tumor. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pituitary Tumor. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top READ MORE >



List of Tables
List of Figures
Introduction
Pituitary Tumor
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Pituitary Tumor
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Pituitary Tumor Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Novartis AG
Clinical Trial Overview of Novartis AG
Eisai Inc.
Clinical Trial Overview of Eisai Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Cedars-Sinai Medical Center
Clinical Trial Overview of Cedars-Sinai Medical Center
St. Joseph's Hospital and Medical Center
Clinical Trial Overview of St. Joseph's Hospital and Medical Center
Huashan Hospital
Clinical Trial Overview of Huashan Hospital
Hofmann, Bernd
Clinical Trial Overview of Hofmann, Bernd
Southern Medical University
Clinical Trial Overview of Southern Medical University
John H. Stroger Hospital
Clinical Trial Overview of John H. Stroger Hospital
The Federico II University
Clinical Trial Overview of The Federico II University
Tohoku University
Clinical Trial Overview of Tohoku University
Postgraduate Institute of Medical Education and Research
Clinical Trial Overview of Postgraduate Institute of Medical Education and Research
Columbia University
Clinical Trial Overview of Columbia University
The National Institute of Diabetes and Digestive and Kidney Diseases
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Neurological Disorders and Stroke
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke
University Hospital Basel
Clinical Trial Overview of University Hospital Basel
University of Florida
Clinical Trial Overview of University of Florida
Assistance Publique - Hopitaux de Paris
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
Pituitary Tumor Therapeutics Market, Global, Clinical Trials by Zone, 2012-
Pituitary Tumor Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Pituitary Tumor Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Pituitary Tumor Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012-
Pituitary Tumor Therapeutics Clinical Trials, Europe, Top Five Countries, 2012-
Pituitary Tumor Therapeutics Clinical Trials, North America, Top Countries, 2012-
Pituitary Tumor Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012-
Pituitary Tumor Therapeutics Clinical Trials, Central and South America, Top Countries, 2012-
Pituitary Tumor Therapeutics Clinical Trials, BRIC Countries, 2012-
Pituitary Tumor Therapeutics Clinical Trials, G7 Countries, 2012-
Pituitary Tumor Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Pituitary Tumor Therapeutics Clinical Trials, E7 Countries, 2012-
Pituitary Tumor Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Pituitary Tumor Therapeutics Market, Global, Clinical Trials by Phase, 2012-
Pituitary Tumor Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012-
Pituitary Tumor Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Pituitary Tumor Therapeutics Market, Global, Suspended Clinical Trials, 2012-
Pituitary Tumor Therapeutics Market, Global, Withdrawn Clinical Trials, 2012-
Pituitary Tumor Therapeutics Market, Global, Terminated Clinical Trials, 2012-
Pituitary Tumor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Pituitary Tumor Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Pituitary Tumor Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Pituitary Tumor Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
Pituitary Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012-
Pituitary Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012-
Pituitary Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Cedars-Sinai Medical Center, 2012-
Pituitary Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Joseph's Hospital and Medical Center, 2012-
Pituitary Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Huashan Hospital, 2012-
Pituitary Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Hofmann, Bernd, 2012-
Pituitary Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Southern Medical University, 2012-
Pituitary Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by John H. Stroger Hospital, 2012-
Pituitary Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by The Federico II University, 2012-
Pituitary Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Tohoku University, 2012-
Pituitary Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Postgraduate Institute of Medical Education and Research, 2012-
Pituitary Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2012-
Pituitary Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2012-
Pituitary Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2012-
Pituitary Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2012-
Pituitary Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2012-
Pituitary Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012-

List of Figures
Pituitary Tumor Therapeutics Market, Global, Clinical Trials by Zone (%), 2012-
Pituitary Tumor Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Pituitary Tumor Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Pituitary Tumor Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012-
Pituitary Tumor Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012-
Pituitary Tumor Therapeutics Clinical Trials, North America, Top Countries (%), 2012-
Pituitary Tumor Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012-
Pituitary Tumor Therapeutics Clinical Trials, BRIC Countries (%), 2012-
Pituitary Tumor Therapeutics Clinical Trials, G7 Countries (%), 2012-
Pituitary Tumor Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Pituitary Tumor Therapeutics Clinical Trials, E7 Countries (%), 2012-
Pituitary Tumor Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Pituitary Tumor Therapeutics Market, Global, Clinical Trials by Phase (%), 2012-
Pituitary Tumor Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012-
Pituitary Tumor Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Pituitary Tumor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Pituitary Tumor Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Pituitary Tumor Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Pituitary Tumor Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
GlobalData Methodology

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos